Molecular genetic study of finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: A novel Gly230Arg mutation (LCAT(Fin)) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 591-598

  Miettinen, H E ^a   Gylling, H ^a   Tenhunen, J ^b   Virtamo, J ^c   Jauhiainen, M ^c   Huttunen, J K ^c   Kantola, I ^d   Miettinen, T A ^a   Kontula, K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ORION CORPORATION   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Cholesterol ester transfer protein; HDL cholesterol; LCAT deficiency; Lipoprotein lipase; Mutation

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; FEMALE; GENETIC LINKAGE; HUMAN; HYPERLIPOPROTEINEMIA; HYPOLIPOPROTEINEMIA; MALE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0031967382     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.591     Document Type: Article

References (20)

1. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
2. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:2031-2052.
3. Assmann G, von Eckardstein A, Funke H. High density lipoproteins, reverse transport of cholesterol and coronary artery disease: insights from mutations. Circulation. 1993;87(suppl III):III-28-III-34.
4. Reymer PWA, Gagne E, Groenemeyer BE, Zhang H, Forsyth O, Jansen H, Seidall JC, Kronhout D, Lie KE, Kastelein J, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet. 1995;10:28-34.
5. Funke H, Assmann G. The low down on lipoprotein lipase. Nat Genet. 1995;10:6-7.
6. Norum KR, Gjone E. Familial plasma lecithin:cholesterol acyltransferase deficiency. Scand J Clin Lab Invest. 1967;20:231-243.
7. Carlson LA, Holmquist L. Evidence for deficiency of high density lipoprotein lecithin:cholesterol acyltransferase activity (α-LCAT) in fish eye disease. Acta Med Scand. 1985;218:189-196.
8. Kuivenhoven JA, Pritchard H, Hill J, Fröhlich J, Assmann G, Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res. 1997:38:191-205.
9. Miettinen H, Gylling H, Ulmanen I, Miettinen TA, Kontula K. Two different allelic mutations in a Finnish family with lecithin:cholesterol acyltransferase (LCAT) deficiency. Arterioscler Thromb Vasc Biol. 1995;15:1-8.
10. Fin: dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene. Arterioscler Thromb Vasc Biol. 1997;17:83-90.
11. Norio R, Nevanlinna HR, Perheentupa J. Hereditary diseases in Finland: rare flora in rare soil. Ann Clin Res. 1973;5:109-141.
12. Nevanlinna HR. The Finnish population structure: a genetic and genealogical study. Hereditas. 1972;71:195-236.
13. Aalto-Setälä K, Helve E, Kovanen PT, Kontula K. The Finnish type of LDL receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxyterminal part of the receptor and creates an internalization-defective phenotype. J Clin Invest. 1989;84:499-505.
14. Koivisto U-M, Turtola H, Aalto-Setälä K, Top B, Frants RR, Kovanen PT, Syvänen A-C, Kontula K. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland. J Clin Invest. 1992;90:219-228.
15. The ATBC cancer prevention study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
16. Kumar R, Dunn L. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. Oncogene Res. 1989;4:156-159.
17. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods and Applications. 1991;1:34-38.
18. McLean J, Wion K, Drayna D, Fielding C, Lawn R. Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res. 1986;14:9397-9406.
19. Sarkar G, Sommer S. The 'megaprimer' method of site-directed mutagenesis. Biotechniques. 1990;8:404-407.
20. Dobiasova M, Schutzova M. Cold labeled substrate and estimation of cholesterol esterification rate in lecithin cholesterol acyltransferase radioassay. Physiol Bohemoslov. 1986;35:319-327.